智通财经APP获悉，百奥赛图-B(02315)盘中涨超7%，截至发稿，涨5.9%，报57.45港元，成交额3372.77万港元。
消息面上，百奥赛图此前发布2025年业绩快报，初步会计数据显示，该公司2025年营收约13.79亿元，实现归母净利1.73亿元，分别同比增长40.63%、416.37%。此外，公司授权IDEAYA的B7H3/PTK7 ADC候选药物IDE034完成1期临床试验首例患者入组，IDEAYA将向公司支付500万美元里程碑付款。
智通财经APP获悉，百奥赛图-B(02315)盘中涨超7%，截至发稿，涨5.9%，报57.45港元，成交额3372.77万港元。
消息面上，百奥赛图此前发布2025年业绩快报，初步会计数据显示，该公司2025年营收约13.79亿元，实现归母净利1.73亿元，分别同比增长40.63%、416.37%。此外，公司授权IDEAYA的B7H3/PTK7 ADC候选药物IDE034完成1期临床试验首例患者入组，IDEAYA将向公司支付500万美元里程碑付款。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.